Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines

Vaccine

Volumn 20, Issue 7-8, 2002, Pages 1030-1038

  Ragupathi, Govindaswami ^a   Cappello, Sarah ^a   Yi, San San ^a   Canter, Dan ^a   Spassova, Maria ^a   Bornmann, William G ^a   Danishefsky, Samuel J ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer vaccines; Conjugate vaccines; Gangliosides; Mucins; Polyvalent vaccines

Indexed keywords

GANGLIOSIDE GD3; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; MUCIN 1; MUCIN 2; QS 21; TUMOR ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG FORMULATION; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEOPLASM; CA-15-3 ANTIGEN; CANCER VACCINES; FEMALE; GANGLIOSIDES; HEMOCYANIN; IMMUNIZATION; LEWIS BLOOD-GROUP SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MUCINS; SAPONINS; VACCINES, CONJUGATE;

EID: 0037081467     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00451-0     Document Type: Article

References (50)

1. Antibodies can eradicate cancer micrometastases
2. The case for melanoma vaccines that induce antibodies
3. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex
4. Immunization of mice with the synthetic hexasaccharide globo H results in antibodies against human cancer cells
5. Augmenting the immunogenicity of synthetic MUC-1 vaccines in mice
6. GD3 vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines
7. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
8. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate vaccines
9. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients
10. Selection of carbohydrate tumor antigens as targets for immune attack using immunohistochemistry. I. Focus on gangliosides
11. Selection of tumor antigens as targets for immune attack using immunohistochemistry. II. Blood group-related antigens
12. Selection of tumor antigens as targets for immune attack using immunohistochemistry. III. Protein antigens
13. Carbohydrate antigens as targets for active specific immunotherapy
14. Glycopeptide- and carbohydrate-based synthetic vaccines for the immunotherapy of cancer
15. Induction of α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice
16. Improved survival in AJCC stage III melanoma patients with GM2 antibodies: A randomized trial of adjuvant vaccination with GM2 ganglioside
17. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic sTn vaccine
18. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin (MUC1)
19. GM2-KLH conjugate vaccine: Increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21
20. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate and immunological adjuvant QS-21
21. y-protein conjugate vaccine: A phase 1 trial
22. Vaccination of high risk breast cancer patients with mucin-1 keyhole limpet hemocyanin conjugate and QS-21
23. Immunogenicity of the fucosyl-GM1-keyhole limpet hemocyanin (KLH) conjugate vaccine in patients with small cell lung cancer
24. A fully synthetic globo H carbohydrate vaccine induces a focused humoral response in prostate cancer patients: A proof of principle
25. Vaccination of breast cancer patients with no evidence of disease (NED) with sialyl Tn cluster stn(c)-keyhole limpet hemocyanin (KLH) conjugate and adjuvant QS-21: Preliminary results
26. 197
27. Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy
28. Opposite effect of actively and passively acquired immunity to the carrier on response of human infants to Haemophilus influenzae type b conjugate vaccine
29. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines
30. Effect of carrier preimmunization on the anti-hapten response in chicken
31. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines
32. Non-epitope-specific suppression of antibody response to Haemophilus influenzae type b conjugate vaccine by preimmunization with vaccine components
33. Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers
34. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in 2-5-year-old children with sickle cell anemia
35. Antibody response to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease
36. Potential alterations in immunogenicity by combining or simultaneously administering vaccines components
37. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside
38. y) blood group antigen expression in epithelial ovarian cancer
39. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin
40. Structure and biology of a carcinoma associated mucin, MUC1
41. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines
42. A randomized prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease
43. Induction of immunologic memory by conjugated versus plain meningococcal C polysaccharide vaccine in toddlers
44. Randomized controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at 2-4 months of age
45. Feasibility study of a combined diphtheris-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs
46. Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at 2-4 months of life
47. Pneumococcal vaccine efficacy in selected populations in the United States
48. Immunology of polysaccharides
49. b blood group determinants and of H-type I and H-type II oligosaccharides